151 related articles for article (PubMed ID: 10756437)
1. [Approaches to gene therapy of hepatocellular carcinoma].
Ameis D
Internist (Berl); 2000 Feb; 41(2 Pt 2):208-12. PubMed ID: 10756437
[No Abstract] [Full Text] [Related]
2. [Gene therapy for hepatocellular carcinoma].
Ohashi M; Kanai F; Shiratori Y; Omata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():699-704. PubMed ID: 11762040
[No Abstract] [Full Text] [Related]
3. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma.
Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N
Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
5. Provocative gene therapy strategy for the treatment of hepatocellular carcinoma.
Askari F; Wilson J
Hepatology; 1992 Jul; 16(1):273-4. PubMed ID: 1319955
[No Abstract] [Full Text] [Related]
6. Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Nakamoto Y; Sakai Y; Marukawa Y; Kitahara M; Mukaida N; Kaneko S
J Immunol; 2007 Jan; 178(1):574-83. PubMed ID: 17182598
[TBL] [Abstract][Full Text] [Related]
7. [Experimental investigation of hepatic arterial embolism treatment with microsphere encapsulation of adenovirus with HSV-TK gene].
Liu ZM; Li XX; Yan LN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):462-5. PubMed ID: 19627006
[TBL] [Abstract][Full Text] [Related]
8. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
9. The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm).
Meng J; Zhang JG; Du ST; Li N
Cancer Gene Ther; 2019 Mar; 26(3-4):114-117. PubMed ID: 30190512
[TBL] [Abstract][Full Text] [Related]
10. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
[TBL] [Abstract][Full Text] [Related]
11. [Gene therapy of primary cancers of the liver: hopes and realities].
Ferry N
Bull Cancer; 1997 Apr; 84(4):431-4. PubMed ID: 9238170
[TBL] [Abstract][Full Text] [Related]
12. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
[TBL] [Abstract][Full Text] [Related]
13. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy for hepatocellular carcinoma. From the idea to clinical trials].
Gerolami R; Uch R; Cardoso J; Bagnis C; Mannoni P; Bréchot C
Gastroenterol Clin Biol; 2001 Mar; 25(3):273-86. PubMed ID: 11395675
[No Abstract] [Full Text] [Related]
16. Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors.
Gerolami R; Uch R; Faivre J; Garcia S; Hardwigsen J; Cardoso J; Mathieu S; Bagnis C; Brechot C; Mannoni P
J Hepatol; 2004 Feb; 40(2):291-7. PubMed ID: 14739101
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recombinant adenoviruses with CD/TK fusion suicide gene on human hepatocellular carcinoma cells].
Wang CJ; Li JJ; Wen XM; Deng L
Zhong Xi Yi Jie He Xue Bao; 2004 Jan; 2(1):42-5. PubMed ID: 15339504
[TBL] [Abstract][Full Text] [Related]
19. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy of liver tumors].
Panis Y; Charre L; Alves A; Soubrane O
J Chir (Paris); 2000 Dec; 137(6):317-24. PubMed ID: 11119025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
